As of 2025-10-18, the EV/EBITDA ratio of Health Catalyst Inc (HCAT) is -61.79. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HCAT's latest enterprise value is 316.94 mil USD. HCAT's TTM EBITDA according to its financial statements is -5.13 mil USD. Dividing these 2 quantities gives us the above HCAT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.8x - 14.5x | 10.2x |
| Forward P/E multiples | 10.0x - 18.7x | 15.6x |
| Fair Price | (2.18) - (2.51) | (2.40) |
| Upside | -171.5% - -182.2% | -178.6% |
| Date | EV/EBITDA |
| 2025-10-16 | -62.34 |
| 2025-10-15 | -61.93 |
| 2025-10-14 | -59.74 |
| 2025-10-13 | -57.13 |
| 2025-10-10 | -56.31 |
| 2025-10-09 | -58.09 |
| 2025-10-08 | -59.05 |
| 2025-10-07 | -59.05 |
| 2025-10-06 | -60.56 |
| 2025-10-03 | -60.56 |
| 2025-10-02 | -58.36 |
| 2025-10-01 | -58.50 |
| 2025-09-30 | -59.05 |
| 2025-09-29 | -60.01 |
| 2025-09-26 | -58.36 |
| 2025-09-25 | -58.50 |
| 2025-09-24 | -59.19 |
| 2025-09-23 | -59.05 |
| 2025-09-22 | -60.42 |
| 2025-09-19 | -59.60 |
| 2025-09-18 | -61.38 |
| 2025-09-17 | -58.50 |
| 2025-09-16 | -59.46 |
| 2025-09-15 | -61.25 |
| 2025-09-12 | -62.89 |
| 2025-09-11 | -64.40 |
| 2025-09-10 | -64.68 |
| 2025-09-09 | -66.60 |
| 2025-09-08 | -66.32 |
| 2025-09-05 | -66.32 |
| 2025-09-04 | -65.22 |
| 2025-09-03 | -64.40 |
| 2025-09-02 | -66.60 |
| 2025-08-29 | -66.46 |
| 2025-08-28 | -70.03 |
| 2025-08-27 | -70.58 |
| 2025-08-26 | -67.97 |
| 2025-08-25 | -65.77 |
| 2025-08-22 | -64.95 |
| 2025-08-21 | -61.93 |
| 2025-08-20 | -60.01 |
| 2025-08-19 | -61.11 |
| 2025-08-18 | -61.11 |
| 2025-08-15 | -60.01 |
| 2025-08-14 | -60.08 |
| 2025-08-13 | -64.13 |
| 2025-08-12 | -61.11 |
| 2025-08-11 | -56.99 |
| 2025-08-08 | -58.78 |
| 2025-08-07 | -70.58 |